HITLAB Announces Inaugural HITLAB Innovators Summit

NEW YORK, Oct. 30, 2014 /PRNewswire-USNewswire/ -- HITLABSM, a healthcare innovation and teaching lab, is pleased to announce its inaugural HITLAB Innovators SummitSM on December 1, 2014 at Columbia University's Low Library. HITLAB will partner with the Clinton Foundation's Health Matters Initiative, Saatchi & Saatchi Wellness, Blueprint Health, ProtoHack, Columbia Business School Alumni Club of New York, and Columbia Industrial Engineering and Operations Research, bringing together leaders in healthcare and technology to address the world's most significant healthcare needs through talks, workshops, demos, and an innovation challenge.

HITLAB Innovators Summit speakers will include Dr. Abdul El-Sayed from Columbia University, Dr. Robert Kelly from New York Presbyterian, Lexie Komisar from the Clinton Foundation, Sharon Suchotliff from Saatchi & Saatchi Wellness, and Josh Stein from AdhereTech, among others. As experts in medicine, technology, design, and policy, they will discuss how transformational technologies and healthcare delivery systems can be applied to global health issues such as chronic care management and access to life-saving technologies.

"We see amazing potential to advance health and wellness through technological and digital innovation, and the HITLAB Innovators Summit is a great opportunity to move this forward," said Lexie Komisar, Associate Director on Digital Health & Innovation for the Clinton Foundation's Health Matters Initiative.

The HITLAB Innovators Summit will also highlight the finalists from this year's HITLAB World CupSM competition, which awards significant funding and networking opportunities for the entrepreneurs and innovators who develop the best original solutions to global healthcare challenges. The first challenge in 2013 propelled winner AdhereTech to form customer relationships with top healthcare companies and raise $1.75 million in funding for its wireless smart pill bottle.

"Digital innovation has played a significant role in healthcare and will continue to shape and influence how people around the world approach health and wellness," said Sharon Suchotliff, VP, Director of Engagement Strategy for Saatchi & Saatchi Wellness. "The HITLAB Innovators Summit is a solutions-oriented event, and we look forward to collaborating and sharing ideas with its participants."

Additional information on the HITLAB Innovators Summit and registration details can be found at www.hitlabsummit.com.  Sponsorship opportunities are available for interested healthcare leaders.

About the HITLAB Innovators SummitSM and HITLAB World CupSM
The HITLAB Innovators Summit brings together leaders from across the globe to share ideas and innovative approaches to addressing global health needs. As part of the daylong event, the HITLAB World Cup challenges entrepreneurs and innovators in healthcare and information technology to tackle global public health issues. www.hitlabsummit.com

About HITLAB
HITLAB is a healthcare innovation and teaching lab with a presence in the United States and India. We ideate, create, and evaluate innovative solutions to healthcare challenges for companies, foundations, multi-lateral agencies, and governments. In partnership with others whose missions align with ours, we independently, ethically, and efficiently design studies, programs, and products that improve healthcare access and quality throughout the world. www.hitlab.org

Media Contact:
Vivian Peng
HITLAB
212-543-0100 
media@hitlab.org

FACEBOOK: http://www.facebook.com/hitlab.org 

TWITTER: @HITLABNYC

SOURCE HITLAB

RELATED LINKS
http://www.hitlab.org

reade more... Résuméabuiyad

Media Alert; NXT-ID Chief Technology Officer Comments on Why You Need a Smart Wallet

SHELTON, Conn., Oct. 27, 2014 /PRNewswire/ -- NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or the "Company"), a biometric authentication company focused on the growing mobile commerce market issues a recent blog entry from Mr. David Tunnell, Chief Technology Officer. Mr Tunnell examines the case for a smart wallet like Wocket™.

With the variety of new payment solutions being released, consumers may ask which method is best? Each new payment method has its own attributes that promise to make payments more convenient and secure. The good news is that none of these new payment methods are mutually exclusive to one another. Each has its own merit depending on where it can be used. For instance, digital wallets such as Google Wallet, Apple Pay or SoftCard (formally ISIS) may be preferable for locations that accept NFC (Near Field Communications), while another solution might be a better choice for locations that require a new barcode payment system such as being developed by major retailers like Wal-Mart, Target and Best Buy. Since none of the new payment methods can be used universally at all locations, the question remains – do you still need a wallet?

Most digital wallets have one thing in common: They all are dependent upon a cell phone. Each new payment method added to a cell phone can be advantageous, depending on when and where you wish to make a payment, but there are always instances where a cell-phone based payment method may not be practical.  A cell phone based payment solution may not be practical when:

Getting money from an ATM. Making a purchase at one of the millions of retail outlets that have not yet replaced their existing point of sale (POS) terminals with new upgraded ones. Making payments in areas with poor connectivity to the Internet. There is a risk that your cell phone battery might run out. Bluetooth does not pair, which may occur with certain methods that require Bluetooth connection with the phone. Then, there is the issue of cash. There are still instances you may need cash or other private information that you want to secure but can't afford to leave at home. These are just some examples of when you may wish you had your wallet with you. 

Smart wallets add electronics to wallets and purses so that you keep your private information secure, only accessible by you. Smart wallets also securely store all of your personal information, not just payment accounts. Furthermore, smart wallets are agnostic to the payment method, capable of supporting new payment methods as they emerge.

So, no matter whether you choose one or more new payment methods associated with your cell phone, there will always be a reason you wished you had a smart wallet. 

We encourage you to take a look at the features of the Wocket™ Smart Wallet and how it might benefit not only your shopping experience, but also all aspects of your wallet by giving you peace of mind with added security to all your personal information.

About NXT- ID Inc. - Mobile Security for a Mobile World: (NXTD) (NXTDW):

NXT-ID, Inc.'s innovative MobileBio® solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio® suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com

NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification that has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com, http://3d-id.net.

Forward-Looking Statements for NXT-ID:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact:

Corporate info: info@nxt-id.com
Investor Inquiries: Kirin Smith
ProActive Capital Group
Direct: +1-646-863-6519
ksmith@proactivecapital.com
Media: 800-665-0411
dvanzant@investorideas.com

SOURCE NXT-ID, Inc.

RELATED LINKS
http://www.wocketwallet.com
http://www.nxt-id.com

reade more... Résuméabuiyad

Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product

DALLAS, Oct. 29, 2014 /PRNewswire/ -- Securus Technologies, a leading provider of civil and criminal justice technology solutions for public safety, investigation, corrections and monitoring, announced today that it has deployed exciting enhancements to its THREADS™ product, which utilizes sophisticated big data analytics to provide actionable intelligence and focused leads for investigators.

Securus Technologies continues to drive technological innovation through identifying and delivering solutions serving the evolving needs of investigators.  Enhancements of the THREADS™ 2.0 release include a redesigned linkage chart with updated visual presentation and improved speed in rendering and manipulation; new Data Import Tools creating uniformity in the import functionality of external and internal data; added capability to import inmate financial transactions in addition to traditional communication details and cell forensics; and improved user control of the Workspace feature.   

"Securus is at the forefront of providing technological solutions desperately needed by our public safety, law enforcement and corrections agency customers," said Robert ("Bob") Pickens, President of Securus Technologies, Inc.  "We continue to seek out opportunities to help our customers do their jobs better and easier, and the THREADS™ 2.0 release does just that.  These enhancements greatly assist investigators, who are exceedingly pressed with less time and resources to uncover critical information for preventing and solving crime."

Kelly Solid, General Manager and acting Product Manager of THREADS™ added, "Even before the 2.0 release, THREADS™ was the most powerful analytical tool on the market.  We have delivered some noteworthy enhancements with the latest release, and are committed to continued development of features that support our customers' need to operate with increased efficiency and effectiveness."

About Securus Technologies
Headquartered in Dallas, Texas, and serving more than 2,600 public safety, law enforcement and corrections agencies and over 1,000,000 inmates across North America, Securus Technologies is committed to serve and connect by providing emergency response, incident management, public information, investigation, verification, communication, information management, inmate self-service, and monitoring products and services in order to make our world a safer place to live. Securus Technologies focuses on connecting what matters™. To learn more about our full suite of civil and criminal justice technology solutions, please visit www.securustech.net.

Logo - http://photos.prnewswire.com/prnh/20100831/DA57799LOGO

SOURCE Securus Technologies, Inc.

RELATED LINKS
http://www.securustech.net

reade more... Résuméabuiyad

Genetic Testing Market Outlook 2018

LONDON, Oct. 22, 2014 /PRNewswire/ -- A recent report, "Genetic Testing Market Outlook 2018", provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in this report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 9% during 2013-2018.

Our report is an outcome of extensive interaction with industry experts which has led us to portray the updated status of genetic testing in various therapeutic areas, major geographies and significant industry applications. The genetic testing industry has seen several new product launches, active research innovations, strategic activities, launch of new DTC tests, and wider therapeutic applications.

The report effectively illustrates the role of genetic testing in diseases such as Cancer, Cystic Fibrosis, and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely, Next-Generation Sequencing, Whole Genome Sequencing, Non Invasive Prenatal Diagnostics, and Personalized Medicine have been covered in the report.

Genetic testing is growing in both developing and developed nations with both industry and research personnel highlighting the significance of molecular biology. The report provides comprehensive analytics of key developments for major markets including the U.S., Europe and Asian countries, and their market overview. Country level analysis depicts the level of penetration for genetic testing, types of tests available, consumer perspectives, regulatory stringency and future growth.

The report also profiles the ten most active genetic testing market players worldwide: Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Life Technologies, Agilent, Hologic, Illumina, Qiagen, Cepheid, and Affymetrix.

Download the full report: https://www.reportbuyer.com/product/1182998/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

RELATED LINKS
http://www.reportbuyer.com

reade more... Résuméabuiyad

Canadian Research Well Represented at HIV Prevention Conference

International conference in Cape Town attracts world-class research from Canada

WINNIPEG, Oct. 27, 2014 /CNW/ - A robust contingent of Canadian researchers will present their work this week at the HIV Research for Prevention (HIV R4P) Conference in Cape Town, South Africa.

The conference to be held from Oct. 28 to 31 is expected to attract up to 1,500 global leaders in HIV prevention, research, programs and policy. HIV R4P is the world's first and only scientific meeting dedicated exclusively to biomedical HIV prevention research.

Twenty nine oral and poster presentations will be made by Canadian researchers, 10 of whom received scholarships from the conference to present their work at HIV R4P. Presentation topics include: subject selection in HIV vaccine trials; the role of hormones in natural protection against HIV-1 in the Kenyan HIV-exposed seronegative cohort; and gay men involved in HIV — their concerns and hopes about pre-exposure prophylaxis (PrEP).

"The sample of Canadian research at HIV R4P is something we can celebrate," says Dr. Allan Ronald, senior scientific advisor of the Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO). "It is also a testament to the ongoing international collaborations Canadian investigators have with researchers in other countries."

Among the Canadian presenters is Dr. Ken Rosenthal, a large team grant principal investigator whose work on innate, adaptive, and mucosal immune responses in HIV-1 exposed uninfected infants in South Africa is funded through the CHVI.

"The HIV R4P Conference is essentially looking at research for prevention, and Canada really has an important role to play in bringing HIV under control," says Rosenthal, who is also the first Visiting Scientist at the Cape Town HIV Vaccine Trials Network (HVTN) Immunology Laboratory. The state-of-the-art South African HIV vaccine research facility is supported by the Hutchinson Center Research Institute of South Africa (HCRISA), and funding for the laboratory's recent renovation was received from the Bill & Melinda Gates Foundation through the CHVI.

"The CHVI really is a driver for a number of reasons," Rosenthal says. "It builds linkages with investigators in developing countries which opens doors for Canadian research collaborations with colleagues in a global fashion."

Ronald adds that the CHVI has achieved some important outcomes since it started in 2007. "It has assisted with building regulatory capacity in low and middle-income countries, secured funding with the Canadian Institutes of Health Research (CIHR) and the Department of Foreign Affairs, Trade and Development (DFATD) for five collaborative scientific teams of Canadians with African colleagues, and facilitated with the Canadian private sector advances in the development of an HIV vaccine," he says.

The CHVI brings together five Government of Canada Departments/Agencies and the Bill & Melinda Gates Foundation to advance progress on HIV vaccine research and development efforts. It also contributes to the prevention of mother-to-child transmission. The establishment of the ACO at the International Centre of Infectious Diseases in Winnipeg in 2011 has facilitated information exchange, collaboration and coordination across diverse national and international research efforts.  

SOURCE Alliance Coordinating Office

RELATED LINKS
http://www.alliance-aco.ca

reade more... Résuméabuiyad